Contraception最新文献

{"title":"Interest in period pills in the United States: A nationally representative survey, 2021–2022","authors":"Ushma D. Upadhyay ,&nbsp;Cari Sietstra ,&nbsp;Leah R. Koenig ,&nbsp;Jennifer Ko ,&nbsp;M. Antonia Biggs","doi":"10.1016/j.contraception.2025.110980","DOIUrl":"10.1016/j.contraception.2025.110980","url":null,"abstract":"<div><h3>Objectives</h3><div>Period pills are a method used to induce bleeding when a menstrual period is late and pregnancy is suspected but not confirmed. This practice enables people to ensure they are not pregnant, without first confirming the existence of a pregnancy. We aimed to measure the extent of interest in period pills.</div></div><div><h3>Study design</h3><div>We used data from a nationally representative panel survey implemented from December 2021 to January 2022 among people ages 15 to 49 assigned female sex at birth to explore interest in and support for period pills after reading descriptive information about them. We estimated the weighted national prevalence of interest in potentially using the pills and support for their availability. We used weighted bivariate logistic regression to examine factors associated with these two outcomes.</div></div><div><h3>Results</h3><div>Among the 6964 participants in the analytic sample, one-quarter (24%, 95% confidence interval [CI]: 22%, 25%) reported that they would consider personally using period pills, and another 19% (95% CI: 17%, 20%) were uncertain. Half of the participants (52%, 95% CI: 50%, 53%) said they were in favor of period pills being available, and another 24% (95% CI: 23%, 26%) were uncertain. Factors associated with both considering using or supporting their availability include being ages 18 to 29 (vs 40–49), completing college, never having been married, having a prior abortion, identifying as lesbian, gay, bisexual, queer or another non-straight sexual orientation, and having experienced barriers to sexual and reproductive health services.</div></div><div><h3>Conclusions</h3><div>There is substantial public interest in and support for period pills, which supports expanding options that enable people to control their fertility.</div></div><div><h3>Implications</h3><div>Given the substantial interest in period pills found in this study, clinicians should consider offering them to patients as an additional option to control their fertility.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"149 ","pages":"Article 110980"},"PeriodicalIF":2.3,"publicationDate":"2025-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144251320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Retraction notice to “The effects of Implanon on lipid metabolism in comparison with Norplant” [Contraception 60 (1999) 281−287]","authors":"Suharti K. Suherman ,&nbsp;Biran Affandi ,&nbsp;Tjeerd Korver","doi":"10.1016/j.contraception.2025.110947","DOIUrl":"10.1016/j.contraception.2025.110947","url":null,"abstract":"","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"148 ","pages":"Article 110947"},"PeriodicalIF":2.8,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144251325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Retraction notice to \"An integrated analysis of nonmenstrual adverse events with Implanon\" [Contraception 58 (1998) S109-S115]","authors":"J. Urbancsek","doi":"10.1016/j.contraception.2025.110948","DOIUrl":"10.1016/j.contraception.2025.110948","url":null,"abstract":"","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"148 ","pages":"Article 110948"},"PeriodicalIF":2.8,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144251321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Retraction notice to “An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon” [Contraception 58 (1998) S99-S107]","authors":"B. Affandi","doi":"10.1016/j.contraception.2025.110949","DOIUrl":"10.1016/j.contraception.2025.110949","url":null,"abstract":"","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"148 ","pages":"Article 110949"},"PeriodicalIF":2.8,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144251322","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Retraction notice to “Pharmacokinetics of Implanon: An integrated analysis” [Contraception 58 (1998) S85-S90]","authors":"J. Huber","doi":"10.1016/j.contraception.2025.110953","DOIUrl":"10.1016/j.contraception.2025.110953","url":null,"abstract":"","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"148 ","pages":"Article 110953"},"PeriodicalIF":2.8,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144251324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacist-prescribed contraception using clinical protocols: A review of the gray literature","authors":"Victoria Anne Chisari ,&nbsp;Helen Benson ,&nbsp;Shalom (Charlie) Benrimoj ,&nbsp;Therese Foran ,&nbsp;Sarah Dineen-Griffin ,&nbsp;Kylie Williams","doi":"10.1016/j.contraception.2025.110979","DOIUrl":"10.1016/j.contraception.2025.110979","url":null,"abstract":"<div><h3>Background</h3><div>Many women face barriers to starting and continuing contraception due to difficulties in accessing primary care. Pharmacist-prescribed contraceptives have emerged as a strategy to improve access. This approach offers an additional pathway for women to access contraceptive care, with benefits such as lower costs, shorter wait times, and extended hours.</div></div><div><h3>Objectives</h3><div>This review aims to analyze clinical protocols used by community pharmacists to prescribe and continue hormonal contraceptives and evaluate their quality.</div></div><div><h3>Study design</h3><div>This review utilized gray literature since protocols are often not formally published. The search involved four processes: searching a gray literature database, using Google, reviewing health agency websites, and consulting international experts. Records were included if they met the definition of a clinical protocol, were for community pharmacist prescribing or continuation of hormonal contraception, and were written in English. Grounded Theory was used for analysis. Quality appraisal was performed using the Appraisal of Guidelines for Research and Evaluation II tool.</div></div><div><h3>Results</h3><div>Thirty clinical protocols were identified from the USA (<em>n</em> = 23), Canada (<em>n</em> = 2), the UK (<em>n</em> = 2), New Zealand (<em>n</em> = 1), and Australia (<em>n</em> = 2). Pharmacists were authorized to prescribe and continue contraceptives in 27 protocols and continue contraceptives only in three. Key requirements included age restrictions, measurement of blood pressure and body mass index, review by a health professional, patient self-completed screening tools, and use of best-practice guidelines. The lowest-scoring domains in the quality assessment were “Editorial Independence,” “Applicability,” and “Rigor of Development.”</div></div><div><h3>Conclusions</h3><div>The review provides insights into the current international landscape of pharmacist-prescribed contraception and highlights key components of clinical protocols. It offers valuable information for policymakers to support the development of frameworks for pharmacist-prescribed contraception globally.</div></div>","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"149 ","pages":"Article 110979"},"PeriodicalIF":2.3,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144201057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Retraction notice to \"Insertion and removal of Implanon\" [Contraception 58 (1998) S79−S83]","authors":"L. Mascarenhas","doi":"10.1016/j.contraception.2025.110951","DOIUrl":"10.1016/j.contraception.2025.110951","url":null,"abstract":"","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"148 ","pages":"Article 110951"},"PeriodicalIF":2.8,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144251323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Retraction notice to \"The pharmacodynamics and efficacy of Implanon: An overview of the data\" [Contraception 58 (1998) S91−S97]","authors":"H.B. Croxatto ,&nbsp;L. Mäkäräinen","doi":"10.1016/j.contraception.2025.110950","DOIUrl":"10.1016/j.contraception.2025.110950","url":null,"abstract":"","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"148 ","pages":"Article 110950"},"PeriodicalIF":2.8,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144251326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Retraction notice to “Introduction: Presentation of clinical data on implanon®1” [Contraception 58 (1998) S75−S77]","authors":"Herjan J.T. Coelingh Bennink","doi":"10.1016/j.contraception.2025.110952","DOIUrl":"10.1016/j.contraception.2025.110952","url":null,"abstract":"","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"148 ","pages":"Article 110952"},"PeriodicalIF":2.8,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144517045","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"New copper intrauterine device approved by FDA in 2025: Longtime coming","authors":"David Hubacher","doi":"10.1016/j.contraception.2025.110899","DOIUrl":"10.1016/j.contraception.2025.110899","url":null,"abstract":"","PeriodicalId":10762,"journal":{"name":"Contraception","volume":"147 ","pages":"Article 110899"},"PeriodicalIF":2.8,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144169894","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}